Venkatraman Seshan

18PUBLICATIONS
183CO-AUTHORS
Solid tumoursHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 20, 2026
Longitudinal Ovarian Reserve in Female Adolescents/Young Adults With Lymphoma: A Report From Children's Oncology Group Study ALTE11C1.

|Jul 10, 2026
Clinical outcomes, patterns of relapse, and molecular landscape of advanced stage high-grade B-cell lymphoma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Jun 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis.

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Jul 17, 2025
Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial.

Raphael Steiner, Liana Nikolaenko, Ranjit Nair

Pageof 3

Frequent Collaborators

7 joint publications

Gilles Salles

7 joint publications

Ahmet Dogan

5 joint publications

Ariela Noy

5 joint publications

Connie Lee Batlevi